The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 15 April 2008, www.theannals.com, DOI 10.1345/aph.1K283.
 The Annals of Pharmacotherapy: Vol. 42, No. 5, pp. 704-707. DOI 10.1345/aph.1K283
© 2008 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.

Desafíos de la Prescripción Basada en la Evidencia en la Práctica Clínica

M Mamdani, A Ching, B Golden, M Melo, y U Menzefricke

Ann Pharmacother 2008;42:704-7.

A pesar de que parece existir un amplio soporte de la medicina basada en la evidencia como base para la racionalización de la prescripción, los desafíos para ello son significativos y, a menudo, justificados. Existen multitud de factores diferentes a la evidencia que dirigen la decisión clínica, incluyendo las preferencias del paciente y los condicionantes sociales, la existencia de interacciones entre enfermedad y medicamento y entre medicamentos, la experiencia clínica, los condicionantes que suponen la existencia de otras condiciones clínicas más importantes, las actividades de marketing y promocionales, y el nivel de implantación de políticas farmacéuticas del sistema. Este trabajo revisa los desafios asociados con la prescripción basada en la evidencia utilizando como ejemplo el cambio de conducta de estatinas durante la introducción de una nueva estatina

Traducido por Corinne Zara Yahni

www.theannals.com, DOI 10.1345/aph.1K283


This article has been cited by other articles:


Home page
 Fam PractHome page
P. B. Rahmner, L. L Gustafsson, J. Larsson, U. Rosenqvist, G. Tomson, and I. Holmstrom
Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs
Fam. Pract., April 1, 2009; 26(2): 121 - 127.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.

homecopy help contact us subscription past issues search current issue
Copyright © 2008 by Harvey Whitney Books Company.